Earnest Partners LLC Dr Reddys Laboratories LTD Transaction History
Earnest Partners LLC
- $21.5 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding RDY
# of Institutions
265Shares Held
107MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$157 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$154 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$138 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$129 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$76.9 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.28B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...